Overseas drugs hit U.S. regulatory snags

Article Abstract:

Despite having received approval by the European Medicines Agency, pharmaceutical companies Novartis, GlaxoSmithKline, and Sanofi-Aventis will have to meet further product safety standards set by the Food and Drug Administration to enter the U.S. market. Article discusses the global sales and marketing of drugs Galvus, Cervarix, and Rimonabant, pharmaceutical companies' efforts to abide by FDA regulations, and Norvartis's possible decision to skip the U.S. market from sale of its medication Galvus.

United States, Product development, Product information, Global Marketing, Economic aspects, Testing, Political aspects, Novartis AG, United States. Food and Drug Administration, Drug approval, GlaxoSmithKline PLC, NVTSY, International marketing, SNY, Sanofi-Aventis S.A., Galvus (Medication), Cervarix (Vaccine)

---

EU plans to drop tariffs on Chinese light bulbs: power-saving items cost two-thirds more in Europe after duties

Article Abstract:

The European Commission will drop antidumping duties on Chinese power-saving light bulbs, as they increase the bulbs' prices by two-thirds for European customers. Germany's Osram has been lobbying to maintain the duties as a competitive advantage over Philips Electronics N.V., its Dutch rival, which manufactures bulbs in China.

China, Household audio and video equipment, Foreign trade, Production management, International economic relations, Taxes, Electric Lighting and Wiring Equipment, Taxation, Netherlands, Germany, Marketing, Consumer electronics industry, International trade, Koninklijke Philips Electronics N.V., Lighting equipment and supplies industry, Lighting equipment industry, European Union. European Commission, Company marketing practices, Antidumping duties, PHG, Light bulbs, Osram GmbH, Trade policy

---

Similar abstracts:

• Abstracts: EU seeks an overhaul of insurance practices. ECB keeps its focus on inflation: bankers signal rates could move higher; euro isn't a threat
• Abstracts: Yukos seeks refuge in U.S. court. Enel plans a bid for Yukos assets: profit falls 22%
• Abstracts: Edge for Northern Rock moves to Branson's Virgin. Flowers may buy Friends Provident
• Abstracts: China's Central Bank provides glimpse into new Yuan policy. China relaxes foreign-bank rules

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.